Stiff person syndrome spectrum disorders; more than meets the eye

J Neuroimmunol. 2022 Aug 15:369:577915. doi: 10.1016/j.jneuroim.2022.577915. Epub 2022 Jun 12.

Abstract

Stiff person syndrome spectrum disorders (SPSD) are a group of rare neuroimmunological disorders that often include painful spasms and rigidity. However, patients have highly heterogeneous signs and symptoms which may reflect different mechanistic disease processes. Understanding subsets of patients based on clinical phenotype may be important for prognosis and guiding treatment. The goal of this review is to provide updates on SPSD and its expanding clinical spectrum, prognostic markers, and treatment considerations. Further, we describe the current understanding in immunopathogenesis and highlight gaps in our knowledge appropriate for future research directions. Examples of revised diagnostic criteria for SPSD based on phenotype are also presented.

Keywords: Autoimmunity; GAD65; Glutamic acid decarboxylase; Stiff person spectrum disorders; Stiff person syndrome.

Publication types

  • Review

MeSH terms

  • Autoantibodies
  • Glutamate Decarboxylase
  • Humans
  • Phenotype
  • Prognosis
  • Stiff-Person Syndrome* / diagnosis
  • Stiff-Person Syndrome* / therapy

Substances

  • Autoantibodies
  • Glutamate Decarboxylase